Submitted by kej2006 on June 6, 2018 - 4:13pm
| Title | THERAPEUTIC VITRECTOMY AS AN ADJUNCT TREATMENT TO SYSTEMIC CHEMOTHERAPY FOR INTRAOCULAR LYMPHOMA. |
| Publication Type | Journal Article |
| Year of Publication | 2017 |
| Authors | Bever GJ, Kim DJ, Afshar AR, Rubenstein JL, Damato BE |
| Journal | Retin Cases Brief Rep |
| Date Published | 2017 Nov 23 |
| ISSN | 1937-1578 |
| Abstract | PURPOSE: To report the outcome of a previously vitrectomized eye having less lymphoma disease burden compared with the contralateral nonvitrectomized eye over the course of 3.5 years while on systemic chemotherapy. METHODS: Case report. RESULTS: A 51-year-old man with vitreoretinal lymphoma with central nervous system involvement underwent vitrectomy in his left eye. Over the following 3.5 years on systemic chemotherapy, the left eye had less lymphoma disease burden compared with the contralateral nonvitrectomized right eye. CONCLUSION: Therapeutic vitrectomy may be a useful adjunct to systemic chemotherapy in vitreoretinal lymphoma, particularly in cases of vitreous predominant disease manifestation. |
| DOI | 10.1097/ICB.0000000000000668 |
| Alternate Journal | Retin Cases Brief Rep |
| PubMed ID | 29210961 |
| Grant List | R01 CA139083 / CA / NCI NIH HHS / United States R21 CA184694 / CA / NCI NIH HHS / United States |